Disulfiram/copper targets stem cell‐like ALDH+ population of multiple myeloma by inhibition of ALDH1A1 and Hedgehog pathway. Issue 8 (17th April 2018)

• Record Type: Journal Article
• Authors: Jin, Na; Zhu, Xiaojian; Cheng, Fanjun; Zhang, Liling
• Is Part Of: Journal of cellular biochemistry. Volume 119:Issue 8(2018)
• Page Start: 6882
• Page End: 6893
• Publication Date: 2018-04-17
• Subjects: aldefluor assay -- ALDH1A1 -- cancer stem cells -- disulfiram/copper -- hedgehog pathway -- multiple myeloma -- multiple myeloma stem cells; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.26885
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Multiple myeloma stem cells (MMSCs) have been considered as the major cause resulting in relapse. Eradicating MMSCs may be an effective strategy to improve the outcome of multiple myeloma (MM). Increased activity of aldehyde dehydrogenase (ALDH) has been found in MMSCs, but whether inhibiting ALDH activity can eliminate MMSCs remains unknown. Disulfiram (DS) has been reported as an inhibitor of ALDH, and increasing studies showed it has anti‐cancer effects in a copper (Cu)‐dependent manner. In this study, we isolated ALDH + cells of MM by Aldefluor assay and demonstrated they possessed tumorigenesis capacities in vitro and in vivo. Next, we investigated the effects of DS with or without Cu on suppressing the stemness of MM both in vitro and in vivo. We found that DS/Cu eliminated the stem cell‐like ALDH + cells. Furthermore, we demonstrated that DS/Cu inhibited the expression of stem cell transcription factors NANOG and OCT4, and abolished the clonogenicity of MM. We also showed that DS/Cu reduced the tumor growth and inhibited stemness of MM in xenograft model. We further found the specific target of DS/Cu is ALDH1A1 and DS/Cu inhibited the Hedgehog (Hh) pathway transcription factors Gli1 and Gli2 regulated by ALDH1A1 at least in part. Our data suggest that DS/Cu can inhibit the ALDH + stem cell‐like cells through ALDH1A1 and Hh pathway, which may be a promising therapeutic agent in eradicating stem cell‐like cells of MM. Abstract : Highlight: (i) ALDH+ cells of MM possess the stem cell‐like properties; (ii) DS/Cu eliminates ALDH+ cells and inhibits stemness of MM; and (iii) DS/Cu inhibits stemness of MM by ALDH1A1 and Hh pathway.